The fourth key finding of this study is that Kaplan-Meier analysis and univariate Cox regression revealed a significant association between higher plasma CLEC-2 levels and improved overall survival, suggesting that CLEC-2 may serve as a favorable prognostic biomarker in breast cancer (Table 4 and Figure 2). Here, CLEC1B is linked to breast cancer.